Bordetella pertussis toxoid antigen (formaldehyde inactivated)

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Brand Names
Vaxelis
Generic Name
Bordetella pertussis toxoid antigen (formaldehyde inactivated)
DrugBank Accession Number
DB14388
Background

Bordetella pertussis toxoid antigen (formaldehyde inactivated) is a vaccine.

Type
Biotech
Groups
Approved
Biologic Classification
Vaccines
Inactivated
Synonyms
  • Bordetella Pertussis Toxoid Antigen, C

Pharmacology

Indication

Not Available

Pharmacology
Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Contraindications
Avoid life-threatening adverse drug events
Improve clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events & improve clinical decision support.
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Adverseeffects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
Learn more
Improve decision support & research outcomes with our structured adverse effects data.
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Products2
Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
ADACELBordetella pertussis toxoid antigen (formaldehyde inactivated) (2.5 mcg/0.5ml) + Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (5 mcg/0.5ml) + Bordetella pertussis pertactin antigen (formaldehyde inactivated) (3 mcg/0.5ml) + Clostridium tetani toxoid antigen (formaldehyde inactivated) (1.5 mg/0.5ml) + Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (2 Lf/0.5ml)Injectionบริษัท ซาโนฟี่ ปาสเตอร์2012-06-27Not applicableThailand flag
ADACEL?-POLIO SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGEBordetella pertussis toxoid antigen (formaldehyde inactivated) (2.5 mcg/0.5ml) + Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (5 mcg/0.5 ml) + Bordetella pertussis fimbriae 2/3 antigen (5 mcg/0,5 ml) + Bordetella pertussis pertactin antigen (3 mcg/0.5 ml) + Clostridium tetani toxoid antigen (formaldehyde inactivated) (5 Lf) + Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (2 Lf) + Poliovirus type 1 antigen (formaldehyde inactivated) (40 D'ag'U) + Poliovirus type 2 antigen (formaldehyde inactivated) (8 D'ag'U) + Poliovirus type 3 antigen (formaldehyde inactivated) (32 D'ag'U)Injection, suspensionIntramuscularSANOFI-AVENTIS SINGAPORE PTE. LTD.2018-05-08Not applicable
Adacel?, Suspension for InjectionBordetella pertussis toxoid antigen (formaldehyde inactivated) (2.5 micrograms) + Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (5 mcg) + Bordetella pertussis fimbriae 2/3 antigen (5 mcg) + Bordetella pertussis pertactin antigen (3 mcg) + Clostridium tetani toxoid antigen (formaldehyde inactivated) (5 Lf) + Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (2 Lf)Injection, suspensionIntramuscularSANOFI-AVENTIS SINGAPORE PTE. LTD.2012-09-20Not applicable
BOOSTAGENBordetella pertussis toxoid antigen (formaldehyde inactivated) (5 mcg) + Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (5 mcg) + Clostridium tetani toxoid antigen (formaldehyde inactivated) (7.5 mg) + Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (2 mg)Injection, suspensionบริษัท ไบโอเนท - เอเชีย จำกัด2019-04-24Not applicableThailand flag
BOOSTRIXBordetella pertussis toxoid antigen (formaldehyde inactivated) (8 mcg/0.5ml) + Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (8 mcg/0.5ml) + Bordetella pertussis pertactin antigen (formaldehyde inactivated) (2.5 mcg/0.5ml) + Clostridium tetani toxoid antigen (formaldehyde inactivated) (20 IU/0.5ml) + Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (2 IU/0.5ml)Injectionบริษัท แกล็กโซสมิทไคล์น (ประเทศไทย) จำกัด2004-03-03Not applicableThailand flag
BOOSTRIX POLIO SUSPENSION FOR INJECTIONBordetella pertussis toxoid antigen (formaldehyde inactivated) (8 mcg/0.5ml) + Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (2.5 Lf/0.5ml) + Poliovirus type 1 antigen (formaldehyde inactivated) (40 DU/0.5ml) + Poliovirus type 3 antigen (formaldehyde inactivated) (32 DU/0.5ml)Injection, suspensionIntramuscularGLAXOSMITHKLINE PTE LTD2020-02-20Not applicable
BOOSTRIX VACCINEBordetella pertussis toxoid antigen (formaldehyde inactivated) (8 mcg/0.5ml) + Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (8 mcg/0.5ml) + Bordetella pertussis pertactin antigen (2.5 mcg/0.5ml) + Clostridium tetani toxoid antigen (formaldehyde inactivated) (20 iu/0.5ml) + Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (2 iu/0.5ml)InjectionIntramuscularGLAXOSMITHKLINE PTE LTD2002-03-09Not applicable
HexacimaBordetella pertussis toxoid antigen (formaldehyde inactivated) (25 mcg) + Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (25 mcg) + Clostridium tetani toxoid antigen (formaldehyde inactivated) (40 IU) + Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (20 IU) + Haemophilus influenzae b polysaccharide-tetanus conjugate (29 mcg) + Hepatitis B Vaccine (Recombinant) (10 mcg) + Poliovirus type 1 antigen (formaldehyde inactivated) (40 D-antigen Units) + Poliovirus type 2 antigen (formaldehyde inactivated) (8 D-antigen Units) + Poliovirus type 3 antigen (formaldehyde inactivated) (32 D-antigen Units)Injection, suspensionIntramuscularSanofi Pasteur2021-03-18Not applicableEU flag
HexacimaBordetella pertussis toxoid antigen (formaldehyde inactivated) (25 mcg) + Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (25 mcg) + Clostridium tetani toxoid antigen (formaldehyde inactivated) (40 IU) + Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (20 IU) + Haemophilus influenzae b polysaccharide-tetanus conjugate (29 mcg) + Hepatitis B Vaccine (Recombinant) (10 mcg) + Poliovirus type 1 antigen (formaldehyde inactivated) (40 D-antigen Units) + Poliovirus type 2 antigen (formaldehyde inactivated) (8 D-antigen Units) + Poliovirus type 3 antigen (formaldehyde inactivated) (32 D-antigen Units)Injection, suspensionIntramuscularSanofi Pasteur2021-03-18Not applicableEU flag
HexacimaBordetella pertussis toxoid antigen (formaldehyde inactivated) (25 mcg) + Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (25 mcg) + Clostridium tetani toxoid antigen (formaldehyde inactivated) (40 IU) + Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (20 IU) + Haemophilus influenzae b polysaccharide-tetanus conjugate (29 mcg) + Hepatitis B Vaccine (Recombinant) (10 mcg) + Poliovirus type 1 antigen (formaldehyde inactivated) (40 D-antigen Units) + Poliovirus type 2 antigen (formaldehyde inactivated) (8 D-antigen Units) + Poliovirus type 3 antigen (formaldehyde inactivated) (32 D-antigen Units)Injection, suspensionIntramuscularSanofi Pasteur2021-03-18Not applicableEU flag

Categories

Drug Categories
Not Available
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
N51SPD4A45
CAS number
Not Available

References

General References
Not Available
Not Available

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4Active Not RecruitingPreventionHuman Papilloma Virus-Related Cervical Carcinoma / Human Papillomavirus Infections1
4CompletedPreventionAcellular Pertussis / Diphtheria / Diphtheria-Tetanus-aPertussis-Hepatitis B-Poliomyelitis-Haemophilus Influenzae Type b Vaccines / Haemophilus Influenzae Serotype b (Hib) / Poliomyelitis / Tetanus / Viral Hepatitis B1
4CompletedPreventionAcellular Pertussis / Diphtheria / Diphtheria-Tetanus-aPertussis-Hepatitis B-Poliomyelitis-Haemophilus Influenzae Type b Vaccines / Poliomyelitis / Tetanus1
4CompletedPreventionDrug Therapy, Combination / Fever, Chemically Induced / Infants / Vaccines, Pneumococcal1
4CompletedPreventionPertussis1
4CompletedPreventionStreptococcal Infections1
4CompletedPreventionVaccines, Pneumococcal1
4RecruitingPreventionDiphtheria1
4TerminatedPreventionImmune Response to DTP-HB-Hib Vaccine1
3CompletedPreventionAcellular Pertussis / Diphtheria / Diphtheria-Tetanus-aPertussis-Hepatitis B-Poliomyelitis-Haemophilus Influenzae Type b Vaccines / Haemophilus Influenzae Serotype b (Hib) / Poliomyelitis / Tetanus / Viral Hepatitis B1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Injection, suspensionIntramuscular5 mcg/0.5 ml
Injection, suspensionIntramuscular5 mcg
Injection, suspension
Injection
Injection, suspensionIntramuscular2.5 Lf/0.5ml
InjectionIntramuscular2 iu/0.5ml
SuspensionIntramuscular
Injection, powder, for suspensionIntramuscular
Injection, suspensionIntramuscular
Injection, suspensionIntramuscular30 iu/0.5ml
InjectionIntramuscular30 iu/0.5ml
InjectionIntramuscular
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created on July 05, 2018 18:02 / Updated on June 12, 2020 16:53